Literature DB >> 6370262

Ethanol metabolism in vivo by the microsomal ethanol-oxidizing system in deermice lacking alcohol dehydrogenase (ADH).

Y Shigeta, F Nomura, S Iida, M A Leo, M R Felder, C S Lieber.   

Abstract

To assess the importance of non-ADH ethanol metabolism, ADH-negative and ADH-positive deermice were fed liquid diets containing ethanol or isocaloric carbohydrate for 2-4 weeks. Blood ethanol disappearance rate increased significantly after chronic ethanol feeding in both strains. Although at low ethanol concentrations (between 5 and 10 mM) there was no significant difference between ethanol-fed and pair-fed control animals, at high ethanol concentrations (between 40 and 70 mM) blood ethanol elimination rates were increased significantly after chronic ethanol feeding in both ADH-positive and ADH-negative animals. There was no significant effect of the catalase inhibitor 3-amino-1,2,4-triazole on the ethanol elimination/rates in both strains. Whereas catalase and ADH activities were not altered after chronic ethanol treatment, the activity of the microsomal ethanol-oxidizing system (MEOS) was enhanced three to four times in both strains, and microsomal cytochrome P-450 content was also increased significantly. When MEOS activity was expressed per cytochrome P-450 content, it was higher in ADH-negative than in ADH-positive animals, and it increased after ethanol administration. When microsomal proteins were separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis, ethanol-fed animals had a distinct band which reflected the increase in microsomal cytochrome P-450 content and seemed to reflect a unique form of cytochrome P-450 induced by ethanol. Thus, despite the absence of the ADH pathway, a large amount of ethanol was metabolized by MEOS in ADH-negative deermice; this was associated with increased blood ethanol elimination rates, enhanced MEOS activity, and quantitative and qualitative changes of cytochrome P-450.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6370262     DOI: 10.1016/0006-2952(84)90466-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Pancreatic injury in hepatic alcohol dehydrogenase-deficient deer mice after subchronic exposure to ethanol.

Authors:  Bhupendra S Kaphalia; Kamlesh K Bhopale; Shakuntala Kondraganti; Hai Wu; Paul J Boor; G A Shakeel Ansari
Journal:  Toxicol Appl Pharmacol       Date:  2010-05-15       Impact factor: 4.219

Review 2.  Interaction of alcohol with other drugs and nutrients. Implication for the therapy of alcoholic liver disease.

Authors:  C S Lieber
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 3.  A new view of alcohol metabolism and alcoholism--role of the high-Km Class III alcohol dehydrogenase (ADH3).

Authors:  Takeshi Haseba; Youkichi Ohno
Journal:  Int J Environ Res Public Health       Date:  2010-03-15       Impact factor: 3.390

4.  Identification of arsenite-and arsenic diglutathione-binding proteins in human hepatocarcinoma cells.

Authors:  Ayano Mizumura; Takayuki Watanabe; Yayoi Kobayashi; Seishiro Hirano
Journal:  Toxicol Appl Pharmacol       Date:  2009-10-27       Impact factor: 4.219

5.  Characteristics of butanol metabolism in alcohol dehydrogenase-deficient deermice.

Authors:  J A Alderman; S Kato; C S Lieber
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

6.  Inhibition of catalase-dependent ethanol metabolism in alcohol dehydrogenase-deficient deermice by fructose.

Authors:  J A Handler; B U Bradford; E B Glassman; D T Forman; R G Thurman
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

7.  Hepatic alcohol dehydrogenase deficiency induces pancreatic injury in chronic ethanol feeding model of deer mice.

Authors:  Samir M Amer; Kamlesh K Bhopale; Ramu D Kakumanu; Vsevolod L Popov; Bill A Rampy; Inas H El-Mehallawi; Magdy M Ashmawy; G A Shakeel Ansari; Bhupendra S Kaphalia
Journal:  Exp Mol Pathol       Date:  2018-01-11       Impact factor: 3.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.